Hematology, Transfusion and Cell Therapy
ISSN: 2531-1379
Hematology, Transfusion and Cell Therapy é uma publicação científica trimestral da Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular (ABHH), Associazione Italo-Brasiliana di Ematologia (AIBE) e Sociedade Brasileira de Oncologia Pediátrica (SOBOPE).
A Hematology, Transfusion and Cell Therapy publica artigos originais, artigos de revisão e relatos de caso relacionados com várias temáticas da área de hematologia e hemoterapia. Até 2017, a revista foi publicada sob o título Revista Brasileira de Hematologia e Hemoterapia.
ISSN print: 2531-1379
ISSN online: 2531-1387
Publicado por Elsevier Editora Ltda, Rio de Janeiro, Brasil.
Indexada em:
LILACS, SciELO Brazil, ESCI (Web of Science), Scopus, and PubMed/PMC
Ver maisSiga-nos no:
CiteScore 2019
O CiteScore mede as citações médias recebidas por documento publicado. Mais informação
CiteScore 2019
1,4
SJR é uma métrica de prestígio baseada na idéia de que todas as citações não são iguais. SJR utiliza um algoritmo similar ao page rank do Google; é uma medida quantitativa e qualitativa ao impacto de uma publicação.
SJR
0,324
SNIP permite comparar o impacto de revistas de diferentes campos temáticos, corrigindo as diferenças na probabilidade de ser citado que existe entre revistas de distintas matérias.
SNIP
0,635
Ocultar
Número
Vol. 42. Núm. 3.Páginas 195-292 (Julho - Setembro 2020)
Special content
Special Content
Special articles
Guidelines for therapy of patients with chronic myeloproliferative neoplasms during the novel coronavirus SARS-CoV2 pandemic
Fabio Pires de Souza Santos, Renato Sampaio Tavares, Katia Borgia Barbosa Pagnano
Hematol Transfus Cell Ther. 2020;42:195-9
Open access
Managing patients with multiple myeloma during the COVID-19 pandemic: recommendations from an expert panel – ABHH monoclonal gammopathies committe
Vania Hungria, Marcia Garnica, Edvan de Queiroz Crusoé, Roberto Jose Pessoa de Magalhaes Filho, Gracia Martinez, Rosane Bittencourt, Danielle Leão Cordeiro de Farias, Walter Moises Braga, Jorge Vaz Pinto Neto, Glaciano Nogueira Ribeiro, Angelo Maiolino
Hematol Transfus Cell Ther. 2020;42:200-5
Open access
Special Content
Case report
Hemodynamics, baroreflex index and blood biomarkers of a patient who died after being affected by COVID-19: case report
Valdenilson Ribeiro Ribas, Renata de Melo Guerra Ribas, Mayara Guerra Souto Barros, Ketlin Helenise dos Santos Ribas, Nery Adamy Neto, Mayanna Guerra Souto Barros, Hugo André de Lima Martins
Hematol Transfus Cell Ther. 2020;42:206-11
Open access
COVID-19 as a trigger of acute chest syndrome in a pregnant woman with sickle cell anemia
Caio Cesar Justino, Felipe Favorette Campanharo, Marina Nobrega Augusto, Stela Cezarino de Morais, Maria Stella Figueiredo
Hematol Transfus Cell Ther. 2020;42:212-4
Open access
COVID-19 presenting as a viral exanthem and detected during admission prescreening in a hematopoietic cell transplant recipient
Nausheen Ahmed, Marcos de Lima, Bethany R. Rohr, Benjamin K. Tomlinson
Hematol Transfus Cell Ther. 2020;42:215-7
Open access
Special Content
Letter to the editor
“Acute” monoclonal gammopathy in severe COVID-19
Natale Vazzana, Silvia Ognibene, Francesco Dipaola
Hematol Transfus Cell Ther. 2020;42:218-20
Open access
Original articles
Investigation of MHC gamma block C4A and C4B polymorphisms in unrelated hematopoietic stem cell transplantation
Joselito Getz, Monica Goldenstein, Carmem Bonfim, Vaneuza Moreira Funke, Vergílio Colturato, Nelson Hamerschlak, Margareth Torres, David Sayer, Angelica Boldt, Ricardo Pasquini, Noemi Farah Pereira
Hematol Transfus Cell Ther. 2020;42:221-9
Open access
A retrospective cohort study to screen linezolid-induced thrombocytopenia in adult patients hospitalized in the Midwestern Region of Brazil
Letícia Souza Lima, Eliana da Costa Alvarenga Brito, Karine Mattos, Eduardo Benedetti Parisotto, Renata Trentin Perdomo, Simone Schneider Weber
Hematol Transfus Cell Ther. 2020;42:230-7
Open access
Clinical and molecular profile of a Brazilian cohort of patients with classical BCR-ABL1-negative myeloproliferative neoplasms
Moysés Antonio Porto-Soares, Rafael Daltro de Oliveira, Gabriel Macedo Cortopassi, João Agostinho Machado-Neto, Leonardo Carvalho Palma, Lorena Lobo de Figueiredo-Pontes
Hematol Transfus Cell Ther. 2020;42:238-44
Open access
Diagnosis of acute graft-versus-host disease in the gastrointestinal tract of patients undergoing allogeneic hematopoietic stem cell transplantation. A descriptive and critical study of diagnostic tests
Leticia Rocha Borges, Eduardo E. Vilela, Maria de Lourdes A. Ferrari, Aloisio S. Cunha, Anilton C. Vasconcelos, Henrique O.G. Torres
Hematol Transfus Cell Ther. 2020;42:245-51
Open access
Current treatment preferences in acute myeloid leukemia: a survey in Brazil
Rodrigo Doyle Portugal, Márcio Luiz Moore Nucci
Hematol Transfus Cell Ther. 2020;42:252-4
Open access
Persistent hematuria among children with sickle cell anemia in steady state
Uzoamaka C. Akubuilo, Adaeze Ayuk, Osita U. Ezenwosu, Uchenna H. Okafor, Ifeoma J. Emodi
Hematol Transfus Cell Ther. 2020;42:255-60
Open access
Review article
Detection of somatic TP53 mutations and 17p deletions in patients with chronic lymphocytic leukemia: a review of the current methods
Maria de Lourdes L.F. Chauffaille, Ilana Zalcberg, Wolney Gois Barreto, Israel Bendit
Hematol Transfus Cell Ther. 2020;42:261-8
Open access
Multidisciplinary diagnostics of chronic lymphocytic leukemia: European Research Initiative on CLL - ERIC recommendations
Ilana Zalcberg, Mariana Gamma D’Andrea, Lucia Monteiro, Glicínia Pimenta, Beth Xisto
Hematol Transfus Cell Ther. 2020;42:269-74
Open access
Asparaginase: an old drug with new questions
Daiane Keller Cecconello, Mariana Rodrigues de Magalhães, Isabel Cristina Ribas Werlang, Maria Lucia de Martino Lee, Mariana Bohns Michalowski, Liane Esteves Daudt
Hematol Transfus Cell Ther. 2020;42:275-82
Open access
Case reports
Short-term dose-escalated romiplostim for preparing an adult patient with persistent newly diagnosed primary immune thrombocytopenia for splenectomy
Nigel P. Murray, Simona Minzer, Marco Antonio López, Lorena Muñoz
Hematol Transfus Cell Ther. 2020;42:283-6
Open access
Successful treatment of catastrophic antiphospholipid syndrome with therapeutic plasma exchange: a case report
Victor Velásquez-Rimachi, Luis Palma-García, Kevin Pacheco-Barrios, Carlos Alva-Díaz
Hematol Transfus Cell Ther. 2020;42:287-91
Open access
Conteúdo especial sobre COVID-19
Publicar em
Hematology, Transfusion and Cell Therapy
A revista pertence ao Committee on Publication Ethics (COPE) www.publicationethics.org e adere aos seus princípios e procedimentos.